Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• Muolokwu, C. E.; Chaulagain, B.; Gothwal, A.; Mahanta, A. K.; Tagoe, B.; Lamsal, B.; Singh, J. Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer's disease. Frontiers in Pharmacology 2024, 15. doi:10.3389/fphar.2024.1405423
• Galindo, A. N.; Frey Rubio, D. A.; Hettiaratchi, M. H. Biomaterial strategies for regulating the neuroinflammatory response. Materials advances 2024, 5, 4025–4054. doi:10.1039/d3ma00736g
• Saleh, S. R.; Abd-Elmegied, A.; Aly Madhy, S.; Khattab, S. N.; Sheta, E.; Elnozahy, F. Y.; Mehanna, R. A.; Ghareeb, D. A.; Abd-Elmonem, N. M. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis. International journal of pharmaceutics 2024, 658, 124218. doi:10.1016/j.ijpharm.2024.124218
• Cogill, S. A.; Lee, J.-H.; Jeon, M.-T.; Kim, D.-G.; Chang, Y. Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood-Brain Barrier. Cells 2024, 13, 789. doi:10.3390/cells13100789
• Sadique, F. L.; Subramaiam, H.; Krishnappa, P.; Chellappan, D. K.; Ma, J. H. RECENT ADVANCES IN BREAST CANCER METASTASIS WITH SPECIAL EMPHASIS ON METASTASIS TO THE BRAIN. Pathology - Research and Practice 2024, 155378. doi:10.1016/j.prp.2024.155378
• Forgham, H.; Zhu, J.; Huang, X.; Zhang, C.; Biggs, H.; Liu, L.; Wang, Y. C.; Fletcher, N.; Humphries, J.; Cowin, G.; Mardon, K.; Kavallaris, M.; Thurecht, K.; Davis, T. P.; Qiao, R. Multifunctional Fluoropolymer-Engineered Magnetic Nanoparticles to Facilitate Blood-Brain Barrier Penetration and Effective Gene Silencing in Medulloblastoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024, e2401340. doi:10.1002/advs.202401340
• He, W.; Wang, N.; Wang, Y.; Liu, M.; Qing, Q.; Su, Q.; Zou, Y.; Liu, Y. Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma. Pharmaceutics 2024, 16, 482. doi:10.3390/pharmaceutics16040482
• Li, Z.; Kovshova, T.; Malinovskaya, J.; Knoll, J.; Shanehsazzadeh, S.; Osipova, N.; Chernysheva, A.; Melnikov, P.; Gelperina, S.; Wacker, M. G. Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin. International journal of nanomedicine 2024, 19, 2039–2056. doi:10.2147/ijn.s440598
• Cai, J.-y.; Liu, Y.; Zhang, L.; Guo, R.-b.; Liu, Y.; Li, X.-t.; Ma, L.-y.; Kong, L. Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma. Journal of Drug Delivery Science and Technology 2024, 93, 105387. doi:10.1016/j.jddst.2024.105387
• Veselý, O.; Živný, M.; Nigríni, M.; Veselý, J.; Čejka, J. The effect of the active site and substrate structure in preparation of substituted tetrahydropyrans via intramolecular cyclization. Catalysis Today 2024, 429, 114465. doi:10.1016/j.cattod.2023.114465
• Battaglini, M.; Marino, A.; Montorsi, M.; Carmignani, A.; Ceccarelli, M. C.; Ciofani, G. Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders. Advanced healthcare materials 2024, 13, e2304180. doi:10.1002/adhm.202304180
• Zha, S.; Liu, H.; Li, H.; Li, H.; Wong, K.-L.; All, A. H. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier. ACS nano 2024, 18, 1820–1845. doi:10.1021/acsnano.3c10674
• Zhao, C.; Zhu, X.; Tan, J.; Mei, C.; Cai, X.; Kong, F. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2024, 171, 116113. doi:10.1016/j.biopha.2023.116113
• Rathnam, S. S.; Deepak, T.; Sahoo, B. N.; Meena, T.; Singh, Y.; Joshi, A. Metallic Nanocarriers for Therapeutic Peptides: Emerging Solutions Addressing the Delivery Challenges in Brain Ailments. The Journal of pharmacology and experimental therapeutics 2024, 388, 39–53. doi:10.1124/jpet.123.001689
• Kapoor, D.; Sharma, D.; Pathak, Y.; Prajapati, B. G.; Satani, B. Nanoformulations targeting Alzheimer's disease. Alzheimer's Disease and Advanced Drug Delivery Strategies; Elsevier, 2024; pp 265–282. doi:10.1016/b978-0-443-13205-6.00010-8
• Chakraborty, P.; Bhattacharyya, C.; Sahu, R.; Dua, T. K.; Kandimalla, R.; Dewanjee, S. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 2024, 91, 105267. doi:10.1016/j.jddst.2023.105267
• Ghosh, B.; Datta, A.; Sarmah, D.; Rana, N.; Chaudhary, A.; Borah, A.; Bhattacharya, P. Nanomaterial-based approach in stroke. Natural Molecules in Neuroprotection and Neurotoxicity; Elsevier, 2024; pp 1935–1958. doi:10.1016/b978-0-443-23763-8.00082-8
• Grosso, C.; Silva, A.; Delerue-Matos, C.; Barroso, M. F. Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders. Pharmaceuticals (Basel, Switzerland) 2023, 16, 1721. doi:10.3390/ph16121721
• Yan, T.-H.; Yuan, M.; Nguyen, N.; Chen, J.; Feng, X.; Fan, T.; Harnett, M. C.; Xiao, Z.; Li, Y.; Pellois, J.-P.; Zhou, H.-C.; Wang, Y. Surface-modified gold-coated superparamagnetic iron oxide nanoparticles promoting light-controlled drug release. Advanced Composites and Hybrid Materials 2023, 6. doi:10.1007/s42114-023-00811-4
• Chen, Y.-J.; Paul, A.; Collins, M. G.; Lee, H. Y. The changing landscape of gene editing tool delivery in neurological disorders. Current Opinion in Biomedical Engineering 2023, 28, 100509. doi:10.1016/j.cobme.2023.100509

Explore citations to this article at